Scinai Immunotherapeutics (SCNI) Capital Expenditures Growth (1y) (2019 - 2026)
Scinai Immunotherapeutics (SCNI) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.74 Bn | 624.08 Mn | -1.12 Mn | 66.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.67% |
| Jun 30, 2025 | 50.00% |
| Mar 31, 2025 | -350.00% |
| Dec 31, 2024 | -97.69% |
| Sep 30, 2024 | 80.00% |
| Jun 30, 2024 | 98.41% |
| Mar 31, 2024 | 66.67% |
| Dec 31, 2023 | -25.82% |
| Sep 30, 2023 | 75.00% |
| Jun 30, 2023 | -756.82% |
| Mar 31, 2023 | -101.15% |
| Dec 31, 2022 | 678.89% |
| Sep 30, 2022 | -1,900.00% |
| Jun 30, 2022 | 58.49% |
| Mar 31, 2022 | 7,542.86% |
| Dec 31, 2021 | 285.57% |
| Sep 30, 2021 | 99.88% |
| Jun 30, 2021 | 91.94% |
| Dec 31, 2020 | 97.15% |
| Sep 30, 2020 | -54.71% |